PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-05-03

Date Title Company
03-May-2022 Japan In-Vitro Diagnostics (IVD) Market Research Report 2022 - ResearchAndMarkets.com Businesswire
03-May-2022 New Publication Highlights Synergistic Potential of CD37-targeted Radioimmunoconjugate Humalutin® in Combination with the PARP-inhibitor Olaparib Nordic Nanovector
03-May-2022 Solvay launches new growth platform focused on renewable materials and biotechnology Solvay
03-May-2022 MIMETAS Expands Adult Stem Cell Organoid License to All Organs MIMETAS
03-May-2022 Engimmune Therapeutics raises CHF 15.5 million in seed financing to develop novel T-cell receptor therapeutics Engimmune Therapeutics
03-May-2022 STORM Therapeutics Awarded Innovate UK Grant to Discover and Develop a Novel Coronavirus Therapy Targeting an RNA-Modifying Enzyme STORM Therapeutics
03-May-2022 Hearables’ Shipments to Exceed 200 Million Globally by 2024, as Vendors Embrace Innovative Use Cases Juniper Research
03-May-2022 Biomunex unveils MAIT cell redirection approach for lead immune-oncology program at PEGS Boston Conference Andrew Lloyd Associates
03-May-2022 BD to Showcase its Deep Commitment to Drug Delivery Excellence at Pharmapack B3C newswire
03-May-2022 End Drug Shortages Alliance Announces Board of Directors, Mission, Vision Statements in First All-Member Meeting Businesswire
03-May-2022 International Pregistry Study Examines Treatments Used for COVID-19 During Pregnancy Businesswire
03-May-2022 Alentis Therapeutics Appoints Dr. Andrea Pellacani as Chief Medical Officer Businesswire
03-May-2022 HAEMATO AG: Dividend of EUR 1.10 HAEMATO AG
03-May-2022 F-star Therapeutics to Announce First Quarter Results and Host Conference Call on Tuesday, May 10th, 2022 F-star Therapeutics
03-May-2022 Edmund Optics® Continuous to Expand in Response to Growth of the Company Edmund Optics®
03-May-2022 HUTCHMED Receives Complete Response Letter from the U.S. FDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors HUTCHMED
03-May-2022 Asia Breast Cancer Screening Market Research Report 2022: Size, Forecasts, Industry Trends, Share, Growth, Impact of COVID-19, Company Analysis 2021-2027 - ResearchAndMarkets.com Businesswire
03-May-2022 NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of its Topical Investigational Drug in the Treatment of Cutaneous Metastases of Breast Cancer Businesswire
03-May-2022 JYSELECA®▼ (filgotinib), recommended by the Health Service Executive (HSE) for people with Ulcerative Colitis (UC) in Ireland Galapagos Biotech LTD
03-May-2022 Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies Businesswire